Quarterly CFO
-$1.73 M
+$1.98 M+53.34%
September 30, 2022
Summary
- As of February 10, 2025, REVBU quarterly cash flow from operations is -$1.73 million, with the most recent change of +$1.98 million (+53.34%) on September 30, 2022.
- Over the past year, REVBU quarterly CFO has increased by +$503.30 thousand (+22.52%).
Performance
REVBU Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$10.27 M
+$503.30 K+4.67%
September 30, 2022
Summary
- As of February 10, 2025, REVBU TTM cash flow from operations is -$10.27 million, with the most recent change of +$503.30 thousand (+4.67%) on September 30, 2022.
- Over the past year, REVBU TTM CFO has dropped by -$2.06 million (-25.09%).
Performance
REVBU TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
REVBU Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +22.5% | -25.1% |
| 3 y3 years | - | +27.3% | -331.2% |
| 5 y5 years | - | +27.3% | -331.2% |
REVBU Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +179.0% | +25.1% | +4.9% | ||
| 5 y | 5-year | at high | +179.0% | +331.2% | +4.9% | ||
| alltime | all time | at high | +179.0% | +331.2% | +4.9% |
Revelation Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.73 M(-53.3%) | -$10.27 M(-4.7%) |
| Jun 2022 | - | -$3.71 M(-23.2%) | -$10.78 M(+1.1%) |
| Mar 2022 | - | -$4.83 M(+116.1%) | -$10.66 M(+29.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$2.23 M(-37.8%) | -$8.21 M(+37.4%) |
| Jun 2021 | - | -$3.60 M(+50.9%) | -$5.98 M(+150.9%) |
| Mar 2021 | - | -$2.38 M | -$2.38 M |
FAQ
- What is Revelation Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Revelation Biosciences?
- What is Revelation Biosciences quarterly CFO year-on-year change?
- What is Revelation Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Revelation Biosciences?
- What is Revelation Biosciences TTM CFO year-on-year change?
What is Revelation Biosciences quarterly cash flow from operations?
The current quarterly CFO of REVBU is -$1.73 M
What is the all time high quarterly CFO for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash flow from operations is -$1.73 M
What is Revelation Biosciences quarterly CFO year-on-year change?
Over the past year, REVBU quarterly cash flow from operations has changed by +$503.30 K (+22.52%)
What is Revelation Biosciences TTM cash flow from operations?
The current TTM CFO of REVBU is -$10.27 M
What is the all time high TTM CFO for Revelation Biosciences?
Revelation Biosciences all-time high TTM cash flow from operations is -$2.38 M
What is Revelation Biosciences TTM CFO year-on-year change?
Over the past year, REVBU TTM cash flow from operations has changed by -$2.06 M (-25.09%)